Clinical Trials Browser

Phase 1 × Interventional × AFM13 × Clear all

NCT02665650 2019-05-16

Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 1 Completed

Hodgkin Disease